計算
P/BV | = | 株価1, 2, 3 | ÷ | 一株当たり簿価1 (BVPS) | BVPS1 | = | イルミナ株主資本1 (単位:百万) |
÷ | 発行済普通株式総数2 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
2021/02/17 | 15.36 | = | 494.24 | ÷ | 32.17 | 32.17 | = | 4,694 | ÷ | 145,900,000 | |
2020/02/11 | 9.43 | = | 296.00 | ÷ | 31.38 | 31.38 | = | 4,613 | ÷ | 147,000,000 | |
2019/02/12 | 11.43 | = | 292.20 | ÷ | 25.56 | 25.56 | = | 3,758 | ÷ | 147,000,000 | |
2018/02/13 | 11.79 | = | 220.44 | ÷ | 18.70 | 18.70 | = | 2,749 | ÷ | 147,000,000 | |
2017/02/14 | 10.95 | = | 164.46 | ÷ | 15.02 | 15.02 | = | 2,197 | ÷ | 146,300,000 | |
2016/03/02 | 12.50 | = | 157.20 | ÷ | 12.58 | 12.58 | = | 1,849 | ÷ | 147,000,000 | |
2015/02/18 | 19.53 | = | 198.62 | ÷ | 10.17 | 10.17 | = | 1,463 | ÷ | 143,800,000 | |
2014/02/18 | 14.25 | = | 170.40 | ÷ | 11.96 | 11.96 | = | 1,533 | ÷ | 128,200,000 | |
2013/02/15 | 4.58 | = | 48.73 | ÷ | 10.63 | 10.63 | = | 1,319 | ÷ | 124,040,754 | |
2012/02/24 | 5.83 | = | 51.22 | ÷ | 8.79 | 8.79 | = | 1,075 | ÷ | 122,327,021 | |
2011/02/28 | 7.40 | = | 69.40 | ÷ | 9.38 | 9.38 | = | 1,198 | ÷ | 127,626,004 | |
2010/02/26 | 5.06 | = | 36.32 | ÷ | 7.18 | 7.18 | = | 864 | ÷ | 120,298,934 | |
2009/02/26 | 4.59 | = | 32.16 | ÷ | 7.01 | 7.01 | = | 849 | ÷ | 121,077,875 | |
2008/02/26 | 10.05 | = | 37.23 | ÷ | 3.71 | 3.71 | = | 412 | ÷ | 111,090,078 | |
2007/02/28 | 8.16 | = | 16.80 | ÷ | 2.06 | 2.06 | = | 247 | ÷ | 120,098,536 | |
2006/03/06 | 14.56 | = | 12.79 | ÷ | 0.88 | 0.88 | = | 72 | ÷ | 82,538,624 |
レポートに基づく: 10-K (報告日: 2020-12-31), 10-K (報告日: 2019-12-29), 10-K (報告日: 2018-12-30), 10-K (報告日: 2017-12-31), 10-K (報告日: 2017-01-01), 10-K (報告日: 2016-01-03), 10-K (報告日: 2014-12-28), 10-K (報告日: 2013-12-29), 10-K (報告日: 2012-12-30), 10-K (報告日: 2012-01-01), 10-K (報告日: 2011-01-02), 10-K (報告日: 2010-01-03), 10-K (報告日: 2008-12-28), 10-K (報告日: 2007-12-30), 10-K (報告日: 2006-12-31), 10-K (報告日: 2006-01-01).
1 米ドル$
2 分割および株式配当を調整したデータ。
3 Illumina Inc.アニュアルレポート提出日時点の終値
競合他社との比較
Illumina Inc. | AbbVie Inc. | Amgen Inc. | Bristol-Myers Squibb Co. | Eli Lilly & Co. | Gilead Sciences Inc. | Johnson & Johnson | Merck & Co. Inc. | Pfizer Inc. | Regeneron Pharmaceuticals Inc. | Thermo Fisher Scientific Inc. | Vertex Pharmaceuticals Inc. | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2021/02/17 | 15.36 | 14.18 | 14.53 | 3.55 | 35.07 | 4.33 | 6.72 | 7.46 | 2.98 | 4.81 | 5.15 | 6.30 |
2020/02/11 | 9.43 | — | 13.84 | 2.80 | 51.67 | 3.93 | 6.61 | 7.83 | 3.00 | 3.79 | 4.16 | 10.23 |
2019/02/12 | 11.43 | — | 9.41 | 5.89 | 12.87 | 3.89 | 6.08 | 7.79 | 3.80 | 5.07 | 3.75 | 10.68 |
2018/02/13 | 11.79 | 36.95 | 5.02 | 8.88 | 7.33 | 5.15 | 5.79 | 4.30 | 2.94 | 5.66 | 3.30 | 20.14 |
2017/02/14 | 10.95 | 21.24 | 4.14 | 5.66 | 6.33 | 4.88 | 4.72 | 4.51 | 3.40 | 8.58 | 2.86 | 18.42 |
2016/03/02 | 12.50 | 22.17 | 3.94 | 7.04 | 5.51 | 6.59 | 4.07 | 3.15 | 2.84 | 10.53 | 2.42 | 22.38 |
2015/02/18 | 19.53 | 56.09 | 4.59 | 6.72 | 5.14 | 10.08 | 4.01 | 3.42 | 2.95 | 16.22 | 2.51 | 25.60 |
2014/02/18 | 14.25 | 18.05 | 4.30 | 5.92 | 3.69 | 11.36 | 3.50 | 3.35 | 2.69 | 16.74 | 2.90 | 14.77 |
2013/02/15 | 4.58 | 18.06 | 3.57 | 4.40 | 4.15 | 7.01 | 3.29 | 2.44 | 2.42 | 12.91 | 1.72 | 10.08 |
2012/02/24 | 5.83 | — | 2.83 | 3.50 | 3.35 | 5.08 | 3.13 | 2.14 | 1.95 | 19.19 | 1.38 | 10.05 |
2011/02/28 | 7.40 | — | 2.04 | 2.76 | 3.21 | 5.29 | 2.88 | 1.85 | 1.75 | 6.42 | 1.41 | 16.16 |
2010/02/26 | 5.06 | — | 2.46 | 2.88 | 4.17 | 6.74 | 3.45 | 1.97 | 1.57 | 5.49 | 1.29 | 7.45 |
2009/02/26 | 4.59 | — | 2.48 | 3.29 | 5.01 | 9.83 | 3.56 | 2.72 | 1.44 | 2.94 | 1.02 | 21.09 |
2008/02/26 | 10.05 | — | 2.77 | 4.22 | 4.16 | 11.76 | 4.17 | 5.38 | 2.32 | 3.24 | 1.62 | 8.92 |
2007/02/28 | 8.16 | — | 3.96 | 5.50 | 5.43 | 18.07 | 4.78 | 5.45 | 2.49 | 5.77 | 1.38 | 7.52 |
2006/03/06 | 14.56 | — | 4.26 | 4.00 | 5.85 | 9.18 | 4.66 | 4.30 | 2.94 | 8.16 | 2.03 | 18.12 |
レポートに基づく: 10-K (報告日: 2020-12-31), 10-K (報告日: 2019-12-29), 10-K (報告日: 2018-12-30), 10-K (報告日: 2017-12-31), 10-K (報告日: 2017-01-01), 10-K (報告日: 2016-01-03), 10-K (報告日: 2014-12-28), 10-K (報告日: 2013-12-29), 10-K (報告日: 2012-12-30), 10-K (報告日: 2012-01-01), 10-K (報告日: 2011-01-02), 10-K (報告日: 2010-01-03), 10-K (報告日: 2008-12-28), 10-K (報告日: 2007-12-30), 10-K (報告日: 2006-12-31), 10-K (報告日: 2006-01-01).
産業部門との比較: 製薬、バイオテクノロジー、ライフサイエンス
Illumina Inc. | 製薬、バイオテクノロジー、ライフサイエンス | |
---|---|---|
2021/02/17 | 15.36 | 6.28 |
2020/02/11 | 9.43 | 6.05 |
2019/02/12 | 11.43 | 6.39 |
2018/02/13 | 11.79 | 5.38 |
2017/02/14 | 10.95 | 4.74 |
2016/03/02 | 12.50 | 4.29 |
2015/02/18 | 19.53 | 4.62 |
2014/02/18 | 14.25 | 4.10 |
2013/02/15 | 4.58 | 3.28 |
2012/02/24 | 5.83 | 2.57 |
2011/02/28 | 7.40 | 2.25 |
2010/02/26 | 5.06 | 2.38 |
2009/02/26 | 4.59 | 2.65 |
2008/02/26 | 10.05 | 3.46 |
2007/02/28 | 8.16 | 3.83 |
2006/03/06 | 14.56 | 4.00 |
レポートに基づく: 10-K (報告日: 2020-12-31), 10-K (報告日: 2019-12-29), 10-K (報告日: 2018-12-30), 10-K (報告日: 2017-12-31), 10-K (報告日: 2017-01-01), 10-K (報告日: 2016-01-03), 10-K (報告日: 2014-12-28), 10-K (報告日: 2013-12-29), 10-K (報告日: 2012-12-30), 10-K (報告日: 2012-01-01), 10-K (報告日: 2011-01-02), 10-K (報告日: 2010-01-03), 10-K (報告日: 2008-12-28), 10-K (報告日: 2007-12-30), 10-K (報告日: 2006-12-31), 10-K (報告日: 2006-01-01).
業界との比較: 医療
Illumina Inc. | 医療 | |
---|---|---|
2021/02/17 | 15.36 | 4.61 |
2020/02/11 | 9.43 | 4.46 |
2019/02/12 | 11.43 | 4.47 |
2018/02/13 | 11.79 | 4.31 |
2017/02/14 | 10.95 | 3.86 |
2016/03/02 | 12.50 | 3.51 |
2015/02/18 | 19.53 | 3.95 |
2014/02/18 | 14.25 | 3.33 |
2013/02/15 | 4.58 | 2.71 |
2012/02/24 | 5.83 | 2.39 |
2011/02/28 | 7.40 | 2.13 |
2010/02/26 | 5.06 | 2.24 |
2009/02/26 | 4.59 | 2.44 |
2008/02/26 | 10.05 | 3.27 |
2007/02/28 | 8.16 | 3.76 |
2006/03/06 | 14.56 | 3.91 |
レポートに基づく: 10-K (報告日: 2020-12-31), 10-K (報告日: 2019-12-29), 10-K (報告日: 2018-12-30), 10-K (報告日: 2017-12-31), 10-K (報告日: 2017-01-01), 10-K (報告日: 2016-01-03), 10-K (報告日: 2014-12-28), 10-K (報告日: 2013-12-29), 10-K (報告日: 2012-12-30), 10-K (報告日: 2012-01-01), 10-K (報告日: 2011-01-02), 10-K (報告日: 2010-01-03), 10-K (報告日: 2008-12-28), 10-K (報告日: 2007-12-30), 10-K (報告日: 2006-12-31), 10-K (報告日: 2006-01-01).